Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects

Clinical trial NCT05807971 · COMPLETED

Trial details

NCT number: NCT05807971
Sponsor: Athos Therapeutics Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases Crohn Disease Ulcerative Colitis Autoimmune Diseases

Start date: 2023-04-06
Primary completion: 2024-02-08
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.